The prognostic significance of early remission of positive symptoms in first treated psychosis

Psychiatry Research

Volumn 218, Issue 1-2, 2014, Pages 44-47

  Norman, Ross M G ^a,b,c   Manchanda, Rahul ^a,b   Windell, Deborah ^b  

^a WESTERN UNIVERSITY   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Disability; Employment; Functioning; Outcomes; Prognosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPETITIVE ABILITY; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; EMPLOYMENT; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PENSION; POSITIVE SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOSIS; PSYCHOSOCIAL CARE; REMISSION; SYMPTOM; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; DISABILITY EVALUATION; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; REMISSION INDUCTION; SCHIZOPHRENIA;

EID: 84902074250     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.04.006     Document Type: Article

References (31)

1. Abel K.M., Drake R., Goldstein J.M. Sex differences in schizophrenia. International Review of Psychiatry 2010, 22:417-428.
2. Alvarez-Jimenez M., Gleeson J.F., Henry L.P., Harrigan S.M., Harris M.G., Amminger G.P., Killackey E., Yung A.R., Herrman H., Jackson H.J., McGorry P.D. Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis. Schizophrenia Research 2011, 125:236-246.
3. Alvarez-Jimenez M., Gleeson J.F., Henry L.P., Harrigan S.M., Harris M.G., Killackey E., Bendall S., Amminger G.P., Yung A.R., Herrman H., Jackson H.J., McGorry P.D. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychological Medicine 2012, 42:595-606.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC.
5. Andreasen N.C. Scale for the Assessment of Negative Symptoms 1983, University of Iowa Press, Iowa City, IA.
6. Andreasen N.C. Scale for the Assessment of Positive Symptoms 1984, University of Iowa, Iowa City, IA.
7. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162:441-449.
8. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 1982, 8:470-484.
9. Cassidy C.M., Norman R., Manchanda R., Schmitz N., Malla A. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. Schizophrenia Bulletin 2010, 36:1001-1008.
10. Cassidy C.M., Rabinovitch M., Schmitz N., Joober R., Malla A. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. Journal of Clinical Pharmacology 2010, 30:64-67.
11. Chang W.C., Chan T.C., Chen E.S., Hui C.L., Wong G.H., Chan S.K., Lee E.H., Chen E.Y. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia. Schizophrenia Research 2013, 143:107-115.
12. Chang Y.M., Wang J.K., Chiu S.N., Lin M.T., Wu E.T., Chen C.A., Huang S.C., Chen Y.S., Chang C.I., Chiu I.S., Lin J.L., Lai L.P., Wu M.H. Clinical spectrum and long-term outcome of Ebstein[U+05F3]s anomaly based on a 26-year experience in an Asian cohort. European Journal of Pediatrics 2009, 168:685-690.
13. Crumlish N., Whitty P., Clarke M., Browne S., Kamali M., Gervin M., McTigue O., Kinsella A., Waddington J.L., Larkin C., O'Callaghan E. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. British Journal of Psychiatry 2009, 194:18-24.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview of DSM-IV Axis 1 (SCID-1) Disorders: Clinical Version 1995, Biometrics Research Department; New York State Psychiatric Institute, New York.
15. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 1984, 10:388-398.
16. Ho B.C., Andreasen N.C., Flaum M., Nopoulos P., Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. American Journal of Psychiatry 2000, 157:808-815.
17. Levine S.Z., Leucht S. Early symptom response to antipsychotic medication as a marker of subsequent symptom change: an eighteen-month follow-up study of recent episode schizophrenia. Schizophrenia Research 2012, 141:168-172.
18. Lieberman J., Jody D., Geisler S., Alvir J., Loebel A., Szymanski S., Woerner M., Borenstein M. Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry 1993, 50:369-376.
19. Loebel A.D., Lieberman J.A., Alvir J.M., Mayerhoff D.I., Geisler S.H., Szymanski S.R. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry 1992, 149:1183-1188.
20. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Australia and New Zealand Journal of Psychiatry 2003, 37:407-413.
21. Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., Harricharan R. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychological Medicine 2006, 36:649-658.
22. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 2005, 62:975-983.
23. McGorry P.D., Edwards J., Mihalopoulos C., Harrigan S.M., Jackson H.J. EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bulletin 1996, 22:305-326.
24. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 2005, 162:495-506.
25. Norman R.M.G., Malla A.K. Course of Onset and Relapse Schedule: Interview and Coding Instruction Guide 2002, Prevention and Early Intervention Program for Psychoses, London, Ontario. 1st ed.
26. Perkins D., Lieberman J., Gu H., Tohen M., McEvoy J., Green A., Zipursky R., Strakowski S., Sharma T., Kahn R., Gur R., Tollefson G. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. British Journal of Psychiatry 2004, 185:18-24.
27. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry 2005, 162:1785-1804.
28. Simonsen E., Friis S., Opjordsmoen S., Mortensen E.L., Haahr U., Melle I., Joa I., Johannessen J.O., Larsen T.K., Rossberg J.I., Rund B.R., Vaglum P., McGlashan T.H. Early identification of non-remission in first-episode psychosis in a two-year outcome study. Acta Psychiatrica Scandinavica 2010, 122:375-383.
29. Susser E., Finnerty M., Mojtabai R., Yale S., Conover S., Goetz R., Amador X. Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophrenia Research 2000, 42:67-77.
30. Wade D., Harrigan S., Edwards J., Burgess P.M., Whelan G., McGorry P.D. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry 2006, 189:229-234.
31. Wunderink L., Sytema S., Nienhuis F.J., Wiersma D. Clinical recovery in first-episode psychosis. Schizophrenia Bulletin 2009, 35:362-369.